Q3/2023: Monthly: Poseida Therapeutics (PSTX: $2.38) in top 3% performers of NASDAQ market in past quarter

Press/Media: Research

PeriodOct 2 2023

Media coverage

2

Media coverage

  • TitleQ3/2023: Monthly: Poseida Therapeutics (PSTX: $2.38) in top 3% performers of NASDAQ market in past quarter
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date10/2/23
    PersonsDavid Jay Hirsch
  • TitlePoseida Therapeutics Compendium - A Snapshot as of September 30, 2023
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date10/2/23
    PersonsDavid Jay Hirsch